THTakao Hashimoto

Takao Hashimoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takao Hashimoto has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Persistently uneven deep brain stimulation management in Japan: a nationwide claims analysis, 2014–2024

    by Jun Tanimura, Takao Hashimoto

    Background: The long-term benefit of deep brain stimulation (DBS) for neurological disorders depends on sustained post-implantation management, yet its geographic distribution remains poorly characterised. We aimed to describe regional variation, persistence, and longitudinal change in DBS management activity across Japan. Methods: We used claims from the National Database of Health Insurance Claims (NDB) Open Data during 2014–2024. Annual billings for DBS management were expressed per million population. Annual between-prefecture unevenness was summarised by the Gini coefficient of the prefecture DBS management billing rate. We evaluated longitudinal trajectories and trends in DBS management billing rates relative to the national rate, and related baseline billing rates to subsequent trends. Findings: From 2014 to 2024, national DBS management billings increased from 18,659 to 27,233, totalling 258,408. Between-prefecture unevenness remained high throughout (Gini coefficient, 0.54 to 0.40), and its narrowing decelerated over the study period. In 2024, the prefecture at the 90th percentile still billed at 9.1 times the rate of the prefecture at the 10th. Of the 23 low-baseline prefectures, nine showed a subsequent decline in relative billing rate; nonetheless, lower baseline DBS management billing rates were associated with a more positive relative rate of change overall. Interpretation: Ongoing post-implantation DBS management activity was markedly uneven and persistent across Japan. The observations suggest that universal health coverage and national-level growth do not by themselves ensure equitable long-term DBS treatment. This nationwide, longitudinal description could inform policies aimed at reducing geographic barriers to long-term specialist care across healthcare systems Funding: None.

  • Clinical Outcomes with Chronic Adaptive Versus Conventional DBS in Parkinson's Disease: A Pilot Randomized Crossover Trial

    by Jun Tanimura, Takehiro Yako, Takao Hashimoto

    Background: Currently available adaptive deep brain stimulation (aDBS) modulates stimulation guided by real‐time beta‐band local field potential activity, potentially offering advantages over conventional DBS (cDBS). Clinical evidence under chronic stimulation remains limited. Objectives: To compare aDBS versus cDBS efficacy in patients with Parkinson's disease (PD) under chronic stimulation. Methods: This was a double‐blind, randomized crossover trial in nine PD patients with bilateral subthalamic nucleus DBS. Patients underwent consecutive one‐month periods of cDBS and aDBS after a four‐month postoperative interval. aDBS used dual‐threshold algorithm adjusting amplitude based on subthalamic beta‐band LFP power. Primary outcomes were daily ON/OFF durations and dyskinesia duration under optimized medication. Mixed‐effects ANCOVA estimated treatment effects. Bayesian analyses integrated prior evidence to assess probabilities of clinically meaningful differences. Results: No statistically significant differences emerged between treatments. Directional effects varied: ON duration favored cDBS, whereas troublesome dyskinesia and UPDRS scores favored aDBS. Bayesian analyses indicated low probabilities that these differences reached clinical importance (29.4% probability for cDBS advantage on ON time, 7.5% for aDBS advantage on UPDRS Part III). Moderate‐to‐substantial between‐patient heterogeneity was observed in comparative treatment effects across outcomes. Conclusions: The current beta‐band LFP‐guided aDBS approach with dual‐threshold algorithm showed efficacy comparable to cDBS in patients with PD. These findings both call for and provide a basis for appropriately powered follow‐up studies to determine whether, for whom, and with which adaptive stimulation strategies aDBS offers greater benefit than cDBS—a key step in the further development of personalized aDBS.

  • Open Access

    Chronic adaptive versus conventional DBS response patterns in Parkinson’s disease: A pilot randomized crossover trial

    by Jun Tanimura, Takehiro Yako, Takao Hashimoto

    Background Adaptive deep brain stimulation (aDBS) modulates stimulation based on real-time biomarkers, potentially offering advantages over conventional DBS (cDBS). Clinical evidence under chronic stimulation remains inconclusive. Objective To compare aDBS versus cDBS efficacy in Parkinson’s disease under chronic stimulation and explore baseline-dependent patterns of comparative treatment response across outcomes. Methods This was a double-blind, randomized crossover trial in nine Parkinson’s disease patients with bilateral subthalamic nucleus DBS. Patients underwent consecutive one-month periods of cDBS and aDBS after a four-month postoperative interval, administered in randomized order. aDBS was delivered using the dual-threshold algorithm that adjusted amplitude in response to subthalamic beta-band LFP power. Primary outcomes were daily ON/OFF durations and dyskinesia duration under optimized medication. A mixed-effects analysis of covariance estimated treatment effects with false discovery rate adjustments. Exploratory analyses examined treatmentby-baseline interactions to characterize patterns of effect modification across outcomes. Results No statistically significant differences emerged between the aDBS and cDBS results. However, heterogeneous directional effects were observed: ON duration measures favored cDBS (1.91 h/day shorter in aDBS), while duration of troublesome dyskinesias (0.10 h/day shorter in aDBS) and total UPDRS scores (5.93 points lower in aDBS) favored aDBS. There was substantial between-patient heterogeneity. Exploratory analyses suggested an overall pattern that higher baseline disease burden enhanced cDBS advantages for motor fluctuations and aDBS advantages for motor severity, though the direction and magnitude of modification effects varied across outcome–baseline combinations. Conclusions aDBS and cDBS showed no significant differences across clinical outcomes under chronic stimulation with optimized medication. The baseline clinical characteristics of patients may shape the results of aDBS. These findings support comparable efficacy between treatments, warranting larger trials to identify patient subgroups who may benefit from each stimulation approach.

  • Effective Target Sites in Thalamic Stimulation for Focal Hand Dystonia

    by Takao Hashimoto, Jun Tanimura, Takehiro Yako

    Introduction: Functional thalamic surgery is known for alleviating isolated focal hand dystonia; however, the optimal target site in the thalamus is not determined. This study aimed to identify effective sites for thalamic deep brain stimulation (DBS) in treating this condition. Methods: Four patients presenting with focal hand dystonia underwent thalamic DBS. Effective stimulation sites were identified through a combination of physiological and radiological mapping. Results: All patients exhibited significant improvement in their hand dystonia. The most effective stimulation sites were localized in the anterior regions of the ventral intermedius nucleus (Vim), involving both Vim and the ventrooral nucleus. Conclusion: Thalamic DBS proves highly effective in managing focal hand dystonia. The identified effective stimulation sites suggest the involvement of both the pallidothalamocortical and cerebellothalamocortical pathways in its pathophysiology.

  • Case of tizanidine withdrawal showing hallucination, decorticate posture and tremor, with hypersympathetic vital signs

    by Jun Tanimura, Takao Hashimoto

    Tizanidine, an α2-adrenergic receptor agonist commonly prescribed as a muscle relaxant, has been associated with limited cases of acute intoxication or withdrawal. Here, we present a case of tizanidine withdrawal in a woman in her 40s who presented with an unusual combination of systemic and neurological symptoms. These included hallucinations, decorticate posture, limb and eyelid tremors, along with hypertension, tachycardia and tachypnoea. The diagnosis of tizanidine withdrawal was established by a comprehensive assessment of the patient’s medical history and the systematic exclusion of other potential diseases. Our approach to managing the withdrawal symptoms was to initiate symptomatic treatment with a combination of a beta-blocker and a calcium channel blocker. Remarkably, this intervention successfully resolved both vital signs and neurological manifestations by the following day. In conclusion, tizanidine withdrawal is associated with a distinct and diagnostically significant neurological syndrome characterised by hallucinations, decorticate posture, tremors and hypersympathetic vital signs.


  • Open Access

    Paramedian Midbrain Infarction Presenting with Bilateral Ptosis and Unilateral Median Longitudinal Fasciculus Syndrome: A Peculiar Midbrain Syndrome

    by Yoshihiro Aoki, Takao Hashimoto

    We report a case of bilateral ptosis due to paramedian midbrain infarction, which was associated with ipsilateral impaired adduction of the eye and contralateral ataxia. T2-weighted magnetic resonance imaging of the brain revealed a right paramedian midbrain infarction. The ptosis rapidly improved without a difference between the left and right sides, while the other symptoms mostly resolved within a month following treatment with antiplatelet agents and rehabilitation. An infarction of the paramedian dorsocaudal portion of the midbrain can involve both the central caudal nucleus and the median longitudinal fasciculus (MLF), causing a peculiar combination of symptoms, bilateral ptosis, and unilateral MLF syndrome.


  • Upward gaze palsy and convergence insufficiency as a rare presentation of primary intraventricular haemorrhage

    by Jun Tanimura, Hiromasa Sato, Masahiro Ebitani, Takao Hashimoto

    A primary intraventricular haemorrhage (PIVH) usually presents with non-localised neurological symptoms since the haematoma is limited to the ventricles. However, it is sometimes associated with focal neurological signs, whose pathophysiologies are not confirmed. Here, we report on a case of PIVH who showed rare manifestations in the acute stage: upward gaze palsy and convergence insufficiency. The CT and MRI showed intraventricular haematoma without evidence of parenchymal haemorrhage, local mass effect around midbrain or hydrocephalus. There had been bilateral papilloedema, and it resolved along with improvement of the ophthalmic symptoms, suggesting a possible causal relation to increased intracranial pressure. The ophthalmic abnormalities suggested injury of the rostral part of the midbrain, especially the region around the dorsal midbrain tectum. It should be known that PIVH is one of the causes of acutely developing upward gaze palsy and convergence insufficiency.

  • Acute cerebral microbleeds at the edge of lacunar strokes: cause or result

    by Keisuke Koizumi, Hiromasa Sato, Masahiro Ebitani, Kikuko Kaneko, Kazuhiro Oguchi, Takao Hashimoto

    We investigated the pathogenic relationship between cerebral microbleeds and lacunar strokes. Two cases of lacunar strokes in the region of the basal ganglia, a 72-year-old man and a 67-year-old man, were studied; both cases showed cerebral microbleeds in the stroke areas. The cerebral microbleeds were surrounded by oedema, and the oedema faded out over time, suggesting the cerebral microbleeds had developed acutely. The cerebral microbleeds were located at the ventrolateral edge of the lacunar infarctions, and the locations appeared to be at or near the sites of occlusion of the lenticulostriatal branches. Although a cerebral microbleed and a lacunar infarction may be two unrelated events on juxtapositioned vessels, or a cerebral microbleed may be haemorrhagic conversion of an infarction, a cerebral microbleed could cause an occlusion of the arterial branch, leading to lacunar infarction of its supplying territories.


  • Long-Term Suppression of Disabling Tremor by Thalamic Stimulation in a Patient with Spinocerebellar Ataxia Type 2

    by Takashi Isobe, Hiromasa Sato, Tetsuya Goto, Takehiro Yako, Kunihiro Yoshida, Takao Hashimoto

    The beneficial effect of thalamic deep brain stimulation (DBS) on action tremor has been reported in a few cases of spinocerebellar ataxia (SCA); however, several factors should be taken into account regarding the indication for DBS in advanced cases. We performed DBS of the ventral intermediate nucleus (Vim) of the thalamus for treatment of coarse action tremor in a patient with SCA2 (spinocerebellar ataxia type 2) in the wheelchair-bound stage. Although improvement of the tremor of the proximal part was incomplete, the patient regained substantial parts of daily functioning. The effect lasted for more than 6 years, and the suppression of tremor significantly contributed to maintaining the level of the patient’s expression into the bedridden stage. Vim DBS can be a treatment option for tremor in SCA patients, even in the advanced stage, as long as the tremor is depriving the patient of behavioral expression. As residual proximal tremor may hamper functional recovery, DBS of other targets or multi-targets should be further explored to attain a better outcome.


  • Successful pallidal surgery for tardive stereotypy

    by Takao Hashimoto, Takashi Isobe, Tetsuya Goto